MOUNTAIN VIEW, Calif.- January 30, 2025 –/BackupReview.info/-—Egnyte, a a leader in secure content collaboration and governance, and Espero, a pioneer in clinical trial eProtocol innovation, today announced a strategic partnership that combines their advanced artificial intelligence (AI) capabilities to revolutionize clinical trial protocol development and management.
This collaboration integrates Egnyte’s Content Intelligence Engine and AI Copilot technology with Espero’s AI-enabled Insights Driven Protocol Platform to deliver a comprehensive, intelligent solution throughout the clinical trial lifecycle. The integration ensures a single source of truth for all protocol-related documents and streamlines workflows with built-in regulatory features, reducing the risk of inconsistencies or errors when managing multiple systems.
“Partnering with Espero marks a significant milestone in our commitment to innovation that benefits the life sciences sector,” said Abhay Kini, director of Life Sciences at Egnyte. “By combining our powerful content collaboration platform with Espero’s groundbreaking eProtocol solutions, we will enable clinical trial organizations to achieve greater efficiency, compliance, and insights, setting a new standard for the future of clinical trial management.”
The integrated platform leverages both companies’ AI technologies to deliver powerful new capabilities, including:
“We are equipping life sciences organizations with the tools they need to streamline protocol development and enhance data integrity by integrating automation processes and our AI-driven insights with Egnyte’s secure content governance,” said Kimberly Tableman, CEO of Espero.
“This partnership is another step in our mission to push the boundaries of what’s possible in clinical innovation.”
The solution includes regulatory documentation and submissions, a GxP-compliant environment meeting 21 CFR Part 11 requirements, real-time collaboration with AI-powered insights, intelligent content classification and security controls, and comprehensive audit trails and compliance monitoring.
The Egnyte-Espero integrated solution is available immediately for life sciences organizations looking to modernize their clinical trial processes. For more information about the partnership and its capabilities, visit Egnyte’s booth (#332) at SCOPE 2025 in Orlando, Fla., from February 3 to 6, or the companies’ websites: www.egnyte.com/life-sciences or www.espero-health.com.
Connect with Egnyte:
About Egnyte
Egnyte combines the power of cloud content management, data security, and AI into one intelligent content platform. More than 22,000 customers trust Egnyte to improve employee productivity, automate business processes, and safeguard critical data, in addition to offering specialized content intelligence and automation solutions across industries, including architecture, engineering, and construction (AEC), life sciences, and financial services. For more information, visit www.egnyte.com
Global Press & Media Contact
media@egnyte.com
Source: Egnyte
Copyright © 2004 - 2020 Backup Review.info | Sitemap
RSS feed for comments on this post · TrackBack URI
Leave a reply